Skip to main content

Nanox Receives FDA Clearance for General Use of New Imaging System, Nanox.ARC X

First FDA clearance for Nanox.ARC X to produce tomographic images for general use, including musculoskeletal, pulmonary, intra-abdominal and paranasal indications Enhanced imaging system features sleek design with smaller footprint; simplified ‘plug and play’ installation process System design enables software upgrades and new capabilities to be added remotely following future regulatory clearancesPETACH TIKVA, Israel, April 17, 2025 (GLOBE NEWSWIRE) — NANO-X IMAGING LTD (“Nanox” or the “Company”, Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Nanox.ARC X, its new multi-source digital tomosynthesis system. The FDA 510(k) clearance was received in less than 30 days from the date...

Continue reading

One Stop Systems CEO and Chairman Issue Letter to Shareholders

ESCONDIDO, Calif., April 17, 2025 (GLOBE NEWSWIRE) — One Stop Systems, Inc. (“We”, “OSS” or the “Company”) (Nasdaq: OSS), a leader in rugged Enterprise Class compute for artificial intelligence (AI), machine learning (ML) and sensor processing at the edge, today issued a shareholder letter, which reviews the progress it made in 2024 and the Company’s expectations for 2025. Dear Fellow Shareholders We are excited to share the progress we made in 2024 and the opportunities ahead to profitably grow our business and create significant value for our shareholders. 2024 was a transformative year for OSS. We successfully executed a strategic transition that not only reshaped our business, but we also believe positioned us at the forefront of one of the most dynamic and rapidly growing markets—high-performance edge compute...

Continue reading

CleanCore Solutions, Inc. (ZONE) Completes Acquisition of Sanzonate Europe, Enhancing Leadership Position within the Industry

Acquisition Delivers Multi-Million-Dollar Sales Pipeline and Significant Working Capital Without an Equity Raise or Dilution Omaha, NE, April 17, 2025 (GLOBE NEWSWIRE) — CleanCore Solutions, Inc. (NYSE American: ZONE) (“CleanCore” or the “Company”), developer of patented technology that works as a safe and low-cost replacement for traditional cleaning chemicals, today announced the successful completion of its acquisition of Sanzonate Europe Ltd. (“Sanzonate”), the largest distributor of aqueous ozone cleaning technologies in Europe. This strategic acquisition strengthens CleanCore’s European market presence, enhances financial performance, and unlocks a multi-million-dollar sales pipeline. The Company expects the transaction to drive immediate revenue growth, bolster profitability, and accelerate its expansion into global markets,...

Continue reading

VERB Closes Acquisition of AI Video Commerce Platform Lyvecom in a Deal Valued at Up to $8.5 Million

Deal Allows VERB’s MARKET.live To Democratize Social Commerce, Offering Brands and Merchants An AI Powered Omnichannel Livestream Shopping Experience With Full Control Over Audience, Content, And Conversions LAS VEGAS and LOS ALAMITOS, Calif., April 17, 2025 (GLOBE NEWSWIRE) — Verb Technology Company, Inc. (Nasdaq: VERB) (“VERB” or the ”Company”), Transforming the Landscape of Social Commerce, Social Telehealth and Social Crowdfunding with MARKET.live; VANITYPrescribed; GoodGirlRx; and the GO FUND YOURSELF TV Show, today announces that the Company, Lyvecom, Inc. (“Lyvecom”) and the shareholders of Lyvecom entered into a definitive Stock Purchase Agreement dated April 11, 2025 (the “Purchase Agreement”) to acquire all of the outstanding capital stock of Lyvecom (the “Acquisition”). The Acquisition closed on April 11, 2025. The purchase...

Continue reading

Runway Growth Finance Corp. Provides First Quarter 2025 Portfolio Update

Completed Three Investments in Existing Portfolio Companies Representing $50.7 Million in Funded Loans MENLO PARK, Calif., April 17, 2025 (GLOBE NEWSWIRE) — Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth” or the “Company”), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today provided an operational and portfolio update for the first quarter ended March 31, 2025. “In the first quarter of 2025, Runway Growth originated high quality financing solutions to several of our existing portfolio companies within the resilient sectors of technology, healthcare and consumer services,” said David Spreng, Founder and CEO of Runway Growth. “As we navigate the current market environment, we are focused on underwriting discipline in our continued effort...

Continue reading

Trump Media Alerts SEC to Potential Manipulation of DJT stock

SARASOTA, Fla., April 17, 2025 (GLOBE NEWSWIRE) — Trump Media and Technology Group Corp. (Nasdaq, NYSE Texas: DJT) (“TMTG” or “the Company”), operator of the social media platform Truth Social, the streaming platform Truth+, and the FinTech brand Truth.Fi, sent the following memo to the U.S. Securities and Exchange Commission: MEMO: Suspicious Trading Activity of DJT Stock To: Mark Uyeda, Acting Chairman, U.S. Securities and Exchange Commission From: Trump Media & Technology Group Date: April 17, 2025Subject: Potential Illegal Naked Short Selling and Market Manipulation of DJT Stock CC: Financial Industry Regulatory Authority (FINRA); Nasdaq; New York Stock Exchange This letter serves to inform you of suspicious activity related to a disclosure filed in Germany by the U.K.-based hedge fund Qube Research...

Continue reading

Woodbridge Closes Sale of MKM Importers, Inc. to Righting Group, LLC

NEW HAVEN, Conn., April 17, 2025 (GLOBE NEWSWIRE) — Woodbridge, a global mergers and acquisitions firm, is pleased to announce the acquisition of its client, MKM Importers, Inc, by Righting Group, LLC. MKM Importers located in Newington, Connecticut is a well-recognized and preferred supplier of pre-owned printing presses and binding equipment. MKM primarily supplies the packaging industry and select large commercial printers in North America but has one of the largest databases of world-wide buyers accumulated over 36 years. “After more than three decades of building MKM into the industry’s trusted source for premium equipment, the time is right to bring in leadership that can take MKM to new heights,” said founder Mark Marino. Righting Group, LLC plays a critical role in middle market transactions – providing current owners with...

Continue reading

Alpha Modus, Corp. Takes Legal Action Against OptiSigns, Inc. for Patent Infringement

CORNELIUS, N.C., April 17, 2025 (GLOBE NEWSWIRE) — Alpha Modus Holdings, Inc. (Nasdaq: AMOD) (“Company”) announced today that its wholly owned subsidiary, Alpha Modus, Corp. (“Alpha Modus”), a leader in AI-driven retail technology, filed a patent infringement lawsuit against OptiSigns, Inc. The lawsuit, filed on April 15, 2025, in the United States District Court for the Southern District of Texas, alleges that OptiSigns has unlawfully utilized Alpha Modus’s proprietary technologies without authorization. The complaint asserts that OptiSigns’s digital signage solutions infringe upon multiple patents held by Alpha Modus, including the ‘571, ‘825, ‘672, ‘890, and ‘880 patents. These patents encompass advanced retail marketing and advertising technologies designed to enhance consumer...

Continue reading

Better Choice Company Reinstates Stock Repurchase Program and Increases Authorization to $6.5 Million

TAMPA, Fla., April 17, 2025 (GLOBE NEWSWIRE) — Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced that its Board of Directors has reinstated its stock repurchase program and increased authorization up to $6.5 million of its outstanding shares of common stock, until December 31, 2025. The Company repurchased 102,405 common shares at an average price of $1.9869 per share under the previous $5 million stock repurchase program, which expired on December 31, 2024. Michael Young, Chairman of Better Choice, commented, “After repurchasing 102,405 common shares under our previous repurchase program in 2024, it is in the best interest of our shareholders to reinstate this program and increase the authorized amount up to $6.5 million as we strongly believe...

Continue reading

Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY® and TWYNEO® in the U.S.

Sol-Gel to receive $16 million during 2025 Cash runway is expected to extend into the first quarter of 2027; Company expects to have sufficient cash to complete its Phase III clinical trial SGT-610 Phase III clinical trial top-line results are expected in the fourth quarter of 2026; a significant milestone in the clinical trial of recruiting more than 80% of the patients has been achieved Sol-Gel now estimates the U.S. market potential for SGT-610 to be between $400 to $500 million annually SGT-210 Phase 1b trial in Darier patients is ongoing; 50% of the patients have already completed the trialNESS ZIONA, Israel, April 17, 2025 (GLOBE NEWSWIRE) — Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company, today announced it has entered into a product purchase agreement with a subsidiary of Mayne Pharma...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.